Drug Common Name Schedule Date of DHEC Schedule Code Section
methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3-methylbutanoate, its isomers, esters, ethers, salts and salts of isomers, esters and ethers FUB-AMB, MMB-FUBINACA, AMB-FUBINACA C-I 11/9/2017 44-53-190(D)
N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide, its isomers, esters, ethers, salts and salts of isomers, esters and ethers Ortho-Fluorofentanyl, 2-Fluorofentanyl C-I 11/9/2017 44-53-190(B)
N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide, its isomers, esters, ethers, salts and salts of isomers, esters and ethers Tetrahydrofuranyl Fentanyl C-I 11/9/2017 44-53-190(B)
2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide, its isomers, esters, ethers, salts and salts of isomers, esters and ethers Methoxyacetyl Fentanyl C-I 11/9/2017 44-53-190(B)
N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide Acryl Fentanyl C-I 8/10/2017 44-53-190(B)
4-Fluoroisobutyryl Fentanyl N-(4-fluorophenyl)-N-(1- phenethylpiperidin-4-yl)isobutyramide (4-fluoroisobutyryl fentanyl or parafluoroisobutyryl fentanyl) C-I 5/11/2017 44-53-190(B)
Dronabinol [(-)-delta-9-trans tetrahydrocannabinol (delta-9-THC)] in an oral solution Syndros C-II 4/5/2017 44-53-210 (Other)
N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide Furanyl Fentanyl C-I 12/8/2016 44-53-190(B)
3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide U-47700, (9547), PINK C-I 11/10/2016 44-53-190(B)
(4-(methoxycarbonyl)-4-(N-phenmethoxyacetamido)-1-[2-(thienyl)ethyl]piperidine) Thiafentanil C-II 9/8/2016 44-53-210(c)
(4-(methoxycarbonyl)-4-(N-phenmethoxyacetamido)-1-[2-(thienyl)ethyl]piperidine) Thiafentanyl C-II 9/8/2016 44-53-210(c)
((2S)-2-[4R)-2-oxo-4-propypyrrolidin-1-yl] butanamide)Brivaracetam BRV, UCB-34714, Briviact C-V 6/9/2016 44-53-270(c)
3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide AH-7921 C-I 5/12/2016 44-53-190(B)
N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide Butyryl Fentanyl C-I 5/12/2016 44-53-190(B)
N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl]piperidin-4-yl]-N-phenylpriopionamide Beta-Hydroxythiofentanyl C-I 5/12/2016 44-53-190(B)
Updated Definition of Substiuted Cathinones to include underlined portion: (4) Substituted Cathinones, Any compound (not being bupropion) structurally derived from 2-amino-1-phenyl-1-propanone by modification in any of the following ways: (a) by substitution in the phenyl ring to any extent with alkyl, alkenyl, alkoxy, alkylendioxy, haloalkyl, or halide subsituents, whether or not further substituted in the phenyl ring by one or more univalent substituents; (b) by substitution at the 3-position with an alkyl substituent; (c) by substitution at the nitrogen atom with alkyl or dialkyl groups, benzyl, or methoxybenzyl groups; or (d) by inclusion of the nitrogen atom in a cyclic structure. Including but not limited to: Methylone, Mephedrone, MDPV, Butylone, Methedrone, 4-MEC, Flephedrone, Pentylone, Pentedrone, Buphedrone, alpha-PVP, 4-MePPP, 4-FMC, 3-FMC, alpha-PBP, naphyrone C-I 3/10/2016 44-53-190(F)
5-[[[(2s)-2-3-[4-aminocarbonyl)-2,6-dimethylphenyl]-1-oxopropyl][(1S)-1-(4-phenyl-1H-imidazol-2-yl)ethyl]amino]methyl]2-methoxybenzoic acid Eluxadoline C-IV 12/10/2015 44-53-250(e)
N-(1- phenethylpiperidin-4-yl)-N-phenylacetamide Acetyl Fentanyl C-I 6/11/2015 44-53-190(B)
Syntehtic Cannabinoids: Indazole-3-carboxamides. Any compound containing an Indazole-3-carboxamide structure with substitution at the nitrogen atom of the indazole ring by alkyl, haloalkyl, halobenzyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, (1-(N-methyl-2-piperidinyl)methyl, (tetrahydro-2H-pyran-4-yl)methyl or (morpholinyl) ethyl group, whether or not further substituted in the indole ring to any extent. Including, but not limited, to AKB-48, AB-FUBINACA, AB-PINACA, ADB-FUBINACA, ADB-PINACA. AKB-48, AB-FUBINACA, AB-PINACA, ADB-FUBINACA, ADB-PINACA, AB-CHMINACA, THJ-2201, 5-Fluoro-AMB C-I 12/11/2014 44-53-190(D)
13-beta-ethyl-17beta-hydroxygon-4-en-3-one Anabolic Steroids 12/11/2014 44-53-1510
17-alpha-methyl-3alpha,17beta-dihydroxy-5alpha-androstane Anabolic Steroids 12/11/2014 44-53-1510
17-alpha-methyl-3beta,17beta-dihydroxy-5alpha-androstane Anabolic Steroids 12/11/2014 44-53-1510
17-alpha-methyl-3beta,17beta-dihydroxyandrost-4-ene Anabolic Steroids 12/11/2014 44-53-1510
17-alpha-methyl-4-hydroxynandrolone Anabolic Steroids 12/11/2014 44-53-1510
17-alpha-methyl-delta1-dihydrotestosterone Anabolic Steroids 12/11/2014 44-53-1510
19-nor-4,9(10)-androstadienedione Anabolic Steroids 12/11/2014 44-53-1510
19-nor-4-androstenediol Anabolic Steroids 12/11/2014 44-53-1510
19-nor-4-androstenedione Anabolic Steroids 12/11/2014 44-53-1510
19-nor-5-androstenediol Anabolic Steroids 12/11/2014 44-53-1510
19-nor-5-androstenedione Anabolic Steroids 12/11/2014 44-53-1510
1-androstenediol Anabolic Steroids 12/11/2014 44-53-1510
1-androstenedione Anabolic Steroids 12/11/2014 44-53-1510
3-alpha,17beta-dihydroxy-5alpha-androstane Anabolic Steroids 12/11/2014 44-53-1510
3-beta,17beta-dihydroxy-5alpha-androstane Anabolic Steroids 12/11/2014 44-53-1510
4-androstenediol Anabolic Steroids 12/11/2014 44-53-1510
4-androstenedione Anabolic Steroids 12/11/2014 44-53-1510
4-dihydrotestosterone Anabolic Steroids 12/11/2014 44-53-1510
4-hydroxy-19-nortestosterone Anabolic Steroids 12/11/2014 44-53-1510
4-hydroxytestosterone Anabolic Steroids 12/11/2014 44-53-1510
5-androstenediol Anabolic Steroids 12/11/2014 44-53-1510
5-androstenedione Anabolic Steroids 12/11/2014 44-53-1510
androstanedione Anabolic Steroids 12/11/2014 44-53-1510
bolasterone Anabolic Steroids 12/11/2014 44-53-1510
boldenone Anabolic Steroids 12/11/2014 44-53-1510
boldione Anabolic Steroids 12/11/2014 44-53-1510
calusterone Anabolic Steroids 12/11/2014 44-53-1510
delta1-dihydrotestosterone Anabolic Steroids 12/11/2014 44-53-1510
desoxymethyltestosterone Anabolic Steroids 12/11/2014 44-53-1510
drostanolone Anabolic Steroids 12/11/2014 44-53-1510
formebolone Anabolic Steroids 12/11/2014 44-53-1510
furazabol Anabolic Steroids 12/11/2014 44-53-1510
mestanolone Anabolic Steroids 12/11/2014 44-53-1510
methandriol Anabolic Steroids 12/11/2014 44-53-1510
methyldienolone Anabolic Steroids 12/11/2014 44-53-1510
methyltrienolone Anabolic Steroids 12/11/2014 44-53-1510
mibolerone Anabolic Steroids 12/11/2014 44-53-1510
norbolethone Anabolic Steroids 12/11/2014 44-53-1510
norclostebol Anabolic Steroids 12/11/2014 44-53-1510
normethandrolone Anabolic Steroids 12/11/2014 44-53-1510
prostanozol Anabolic Steroids 12/11/2014 44-53-1510
stenbolone Anabolic Steroids 12/11/2014 44-53-1510
testolactone Anabolic Steroids 12/11/2014 44-53-1510
tetrahydrogestrinone Anabolic Steroids 12/11/2014 44-53-1510
trenbolone Anabolic Steroids 12/11/2014 44-53-1510
2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine 2C-E C-I 12/11/2014 44-53-190(D)
2-(4-Iodo-2,5-dimethoxyphenyl) ethanamine 2C-I C-I 12/11/2014 44-53-190(D)
4-Bromo-2,5-dimethoxyphenethylamine 2C-B C-I 12/11/2014 44-53-190(D)
1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine PEPAP C-I 12/11/2014 44-53-190(B)
1-[1-(2-Thienyl)cyclohexyl]pyrrolidine TCPy C-I 12/11/2014 44-53-190(D)
1-Methyl-4-phenyl-4-propionoxypiperidine MPPP C-I 12/11/2014 44-53-190(B)
2-(2,5-Dimethoxy-4-(n)-prophylphenyl) ethanamine 2C-P C-I 12/11/2014 44-53-190(D)
2-(2,5-Dimethoxy-4-methylphenyl) ethanamine 2C-D C-I 12/11/2014 44-53-190(D)
2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine 2C-N C-I 12/11/2014 44-53-190(D)
2-(2,5-Dimethoxyphenyl) ethanamine 2C-H C-I 12/11/2014 44-53-190(D)
2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine 2C-C C-I 12/11/2014 44-53-190(D)
2-(4-ethylthio-2,5-dimethoxyphenyl) ethanamine 2C-T-2 C-I 12/11/2014 44-53-190(D)
2-(4-ethylthio-2,5-dimethoxyphenyl) ethanamine 2C-T-4 C-I 12/11/2014 44-53-190(D)
2,5-Dimethoxy-4-(n)propylthiophenethylamine 2C-T-7 C-I 12/11/2014 44-53-190(D)
2,5-Dimethoxy-4-ethylamphetamine DOE, DOET, Hecate C-I 12/11/2014 44-53-190(D)
3,4-Methylenedioxy-N-ethylamphetamine MDEA C-I 12/11/2014 44-53-190(D)
3-Methoxy-4,5-methylenedioxyamphetamine MMDA C-I 12/11/2014 44-53-190(D)
3-Methylfentanyl C-I 12/11/2014 44-53-190(B)
3-Methylthiofentanyl C-I 12/11/2014 44-53-190(B)
4-Methylaminorex (cis isomer) C-I 12/11/2014 44-53-190(F)
5 Methoxy-N,N,Dimethyltryptamine 5-MeO-DMT C-I 12/11/2014 44-53-190(D)
5-Iodo-2-aminoindane 5-IAI C-I 12/11/2014 44-53-190(D)
5-Methoxy-N,N-diisopropyltryptamine 5-MeO-DIPT C-I 12/11/2014 44-53-190(D)
Acetyl-alpha-methylfentanyl C-I 12/11/2014 44-53-190(B)
Alpha-ethyltryptamine alpha-ET C-I 12/11/2014 44-53-190(D)
Alpha-methylthiofentanyl C-I 12/11/2014 44-53-190(B)
Alpha-methyltryptamine AMT C-I 12/11/2014 44-53-190(D)
Aminorex C-I 12/11/2014 44-53-190(F)
Beta-hydroxy-3-methylfentanyl C-I 12/11/2014 44-53-190(B)
Beta-hydroxyfentanyl C-I 12/11/2014 44-53-190(B)
Cyclohexamine Ethylamine analog of phencyclidine, PCE C-I 12/11/2014 44-53-190(D)
N,N-Dimethylamphetamine Metrotonin C-I 12/11/2014 44-53-190(F)
N-Benzylpiperazine BZP C-I 12/11/2014 44-53-190(F)
Para-Fluorofentanyl C-I 12/11/2014 44-53-190(B)
Rolicyclidine Pyrrolidine analog of phencyclidine, PHP, PCPy C-I 12/11/2014 44-53-190(D)
Synthetic Cannabinoid: Indole -3-carboxamides. Any compound containing an Indole-3-carboxamide structure with substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, (1-(N-methyl-2-piperidinyl)methyl, (tetrahydro-2H-pyran-4-yl)methyl or (morpholinyl) ethyl group, whether or not further substituted in the indole ring to any extent. Including, but not limited, to STS-135. STS-135 C-I 12/11/2014 44-53-190(D)
Synthetic Cannabinoid: Indazole-3-carboxamides. Any compound containing an Indazole-3-carboxamide structure with substitution at the nitrogen atom of the indazole ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, (1-(N-methyl-2-piperidinyl)methyl, (tetrahydro-2H-pyran-4-yl)methyl or (morpholinyl) ethyl group, whether or not further substituted in the indole ring to any extent. Including, but not limited, to AKB-48, AB-FUBINACA, AB-PINACA, ADB-FUBINACA, ADB-PINACA. AKB-48, AB-FUBINACA, AB-PINACA, ADB-FUBINACA, ADB-PINACA, AB-CHMINACA, THJ-2201, 5-Fluoro-AMB C-I 12/11/2014 44-53-190(D)
Synthetic Cannabinoid: N-cyclopropyl-11-(2-hexyl-5-hydroxyphenoxy)-undecanamide CB-52 C-I 12/11/2014 44-53-190(D)
Synthetic Cannabinoid: N-cyclopropyl-11-(3-hydroxy-5-pentylphenoxy)-undecanamide CB-25 C-I 12/11/2014 44-53-190(D)
Synthetic Cannabinoid: N-cyclopropyl-8-[3-(1,1-dimethylheptyl)-5-hydroxyphenoxy]-octanamide CB-86 C-I 12/11/2014 44-53-190(D)
Synthetic Cannabinoid: (6aR,9R,10aR)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,8,9,10,10a-hexahydrobenzo [c]chromene-1,9-diol HU-243, Canbisol C-I 12/11/2014 44-53-190(D)
Synthetic Cannabinoid: [(6S,6aR, 9R,10aR)-9-hydroxy-6-methyl-3-[(2R)-5-phenylpentan-2-yl]oxy-5,6,6a,7,8,9,10,10a-octahydrophenanthridin-1-yl] acetate Levantradol, CP 50,556-1 C-I 12/11/2014 44-53-190(D)
Synthetic Cannabinoid: 1-napthalenyl[4-(pentylox)-1-napthalenyl]-methanone CB-13, CRA-13 C-I 12/11/2014 44-53-190(D)
Synthetic Cannabinoid: 3-hydroxy-2-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-2,5-cyclohexadiene-1,4-dione HU-331 C-I 12/11/2014 44-53-190(D)
Synthetic Cannabinoid: 4-[4-(1,1-dimethylheptyl)-2,6-dimethoxyphenyl]-6,6-dimethyl-bicyclo[3.1.1] hept-2-ene-2-methanol HU-308 C-I 12/11/2014 44-53-190(D)
Synthetic Cannabinoids: Quinolinyl-Indole Carboxylates. Any compound containing a quinolinyl-indole-3-carboxylate structure with substitution of the nitrogen atom of the indole ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, (1-(N-methyl-2-piperidinyl)methyl, (tetrahydro-2H-pyran-4-yl)methyl or (morpholinyl) ethyl group, whether or not further substituted in the indole ring or quinolinyl structure to any extent. Including but not limited to PB-22, 5-F-PB-22. PB-22; 5-F-PB-22; BB-22 C-I 12/11/2014 44-53-190(D)
Synthetic Cannaninoid: Indole - 3-ylcycloalkyl ketones. Any compound containing an Indole-3-ylcycloalkyl ketone structure with substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, (1-(N-methyl-2-piperidinyl)methyl, (tetrahydro-2H-pyran-4-yl)methyl or (morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent or whether or not substituted at the cycloalkyl ring to any extent. Including, but not limited to, XLR-11, UR-144, A-834735, A-796260, AB-001, AB-005 XLR-11, UR-144, A-834735, A-796260, AB-001, AB-005, 5-bromo-UR-144, 5-chloro-UR-144, 5-fluoro-144, AB-034 C-I 12/11/2014 44-53-190(D)
Tenocyclidine 1-[1-(2-Thienyl)cyclohexyl]piperidine, TCP C-I 12/11/2014 44-53-190(D)
Thiofentanyl C-I 12/11/2014 44-53-190(B)
4-Anilino-N-phenethyl-4-piperidine ANPP C-II 12/11/2014 44-53-210(c)
Alfentanil C-II 12/11/2014 44-53-210(c)
Dihydroetorphine C-II 12/11/2014 44-53-210(c)
Diprenorphine C-II 12/11/2014 44-53-210(c)
Levo-alphacetylmethadol LAAM C-II 12/11/2014 44-53-210(c)
Lisdexamfetamine C-II 12/11/2014 44-53-210(d)
Nabilone C-II 12/11/2014 44-53-210(h)
Oripavine C-II 12/11/2014 44-53-210(c)
Oxycodone C-II 12/11/2014 44-53-210(c)
Remifentanil C-II 12/11/2014 44-53-210(c)
Tapentadol C-II 12/11/2014 44-53-210(c)
Thebaine C-II 12/11/2014 44-53-210(c)
Buprenorphine C-III 12/11/2014 44-53-230(e)
Dronabinol in sesame oil and encapsulated in a soft gelatin capsule marinol - synthetic delta 9 tetrahydrocannabinol (THC) C-III 12/11/2014 44-53-230(e)
Embutramide C-III 12/11/2014 44-53-230(c)
Ketamine C-III 12/11/2014 44-53-230(c)
Sulfonmethane C-III 12/11/2014 44-53-230(c)
Tiletamine & Zolazepam Combination Product C-III 12/11/2014 44-53-230(c)
Cathine C-IV 12/11/2014 44-53-250(b)
Dichloralphenazone C-IV 12/11/2014 44-53-250(a)
Etizolam C-IV 12/11/2014 44-53-250(a)
Fencamfamin C-IV 12/11/2014 44-53-250(b)
Fenproporex C-IV 12/11/2014 44-53-250(b)
Fospropofol C-IV 12/11/2014 44-53-250(a)
Mefenorex C-IV 12/11/2014 44-53-250(b)
Midazolam C-IV 12/11/2014 44-53-250(a)
Modafinil C-IV 12/11/2014 44-53-250(b)
Phenazepam C-IV 12/11/2014 44-53-250(a)
Pyrazolam C-IV 12/11/2014 44-53-250(a)
Quazepam C-IV 12/11/2014 44-53-250(a)
Sibutramine C-IV 12/11/2014 44-53-250(b)
Zaleplon C-IV 12/11/2014 44-53-250(a)
Zolpidem C-IV 12/11/2014 44-53-250(a)
Zopiclone C-IV 12/11/2014 44-53-250(a)
Lacosamide C-V 12/11/2014 44-53-270(c)
Pregabalin C-V 12/11/2014 44-53-270(c)
Pyrovalerone C-V 12/11/2014 44-53-270(d)
[(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl}{5=methyl-2-(2H-123-triazol-2-yl)phenyl]methanone Suvorexant C-IV 9/25/2014 44-53-250(a)
Dihydrocodeine - Not more than 1.8 grams of dihydrocodeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active, non-narcotic ingredients in recognized therapeutic amounts. C-II 9/11/2014 44-53-230(e)
Dihydrocodeine - Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more than 15 milligrams per dosage unit, with a four-fold or greater quantity of an isoquinoline alkaloid of opium. C-II 9/11/2014 44-53-230(e)
Dihydrocodeine - Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more than 15 milligrams per dosage unit, with one or more active, non-narcotic ingredients in recognized therapeutic amounts. C-II 9/11/2014 44-53-230(e)
Hydrocodone Combination Products Lortab C-II 9/11/2014 44-53-210(c)
2-[(dimethylamino)methyl]-1-(3-Methoxyphenyl)cyclohexanol Tramadol C-IV 7/10/2014 44-53-250(e)
Alfaxalone Alfaxalone C-IV 3/13/2014 44-53-250(a)
Synthetic Cannabinoid: N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide ADB-PINACA C-I 2/27/2014 44-53-190(D)
Synthetic Cannabinoid: N-(1-amino-3-methyl-1-oxobutan-2-yl-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide AB-FUBINACA C-I 2/27/2014 44-53-190(D)
Synthetic Cannabinoid: Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3 carboxylate 5-fluoro-PB-22; 5F-PB-22 C-I 2/27/2014 44-53-190(D)
Synthetic Cannabinoid: Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate PB-22; QUPIC C-I 2/27/2014 44-53-190(D)
2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine 25B-NBOMe; 2C-B-NBOMe; 25B; Cimbi-36 C-I 12/12/2013 44-53-190(D)
2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine 25C-NBOMe; 2C-C-NBOMe; 25C; Cimbi-82 C-I 12/12/2013 44-53-190(D)
2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine 25I-NBOMe; 2C-I-NBOMe; 25I; Cimbi-5 C-I 12/12/2013 44-53-190(D)
Lorcaserin Lorcaserin C-IV 6/4/2013 44-53-250(c)
Synthetic Cannabinoid: 1-(5-fluoro-pentyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl) methanone 5-fluoro-UR-144; XLR-11; XLRl 1 C-I 5/9/2013 44-53-190(D)
Synthetic Cannabinoid: 1-pentyl-1H-indol-3-yl(2,2,3,3-tetramethylcyclopropyl) methanone UR-144 C-I 5/9/2013 44-53-190(D)
Synthetic Cannabinoid: N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide APINACA, AKB48 C-I 5/9/2013 44-53-190(D)
Carisoprodol Soma C-IV 2/9/2012 44-53-250(a)
Carisoprodol+Aspirin SOMA Compound C-IV 2/9/2012 44-53-250(a)
3,4-methylenedioxy-N-methylcathinone Methylone C-I 10/24/2011 44-53-190(F)
3,4-methylenedioxypyrovalerone MDPV C-I 10/24/2011 44-53-190(F)
4-methyl-N-methylcathinone Mephedrone C-I 10/24/2011 44-53-190(F)
Synthetic Cannabinoid: 1-Butyl-3-(1-napthoyl)indole JWH-073 C-I 10/24/2011 44-53-190(D)
Synthetic Cannabinoid: 1-Pentyl-3-(1-napthoyl)indole JWH-018; AM678 C-I 10/24/2011 44-53-190(D)
Synthetic Cannabinoid: 5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol CP-47,497 C-I 10/24/2011 44-53-190(D)
Synthetic Cannabinoid: 5-(1,1-Dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol cannabicyclohexanol; CP-47,497 C8 homologue C-I 10/24/2011 44-53-190(D)
Synthetic Cannabinoid: 1-[2-(4-Morpholinyl)ethyl]-3-(1-napthoyl)indole JWH-200 C-I 10/24/2011 44-53-190(D)
Ethylestrenol Anabolic Steroids 44-53-1510
Fluoxymesterone Anabolic Steroids 44-53-1510
Mesterolone Anabolic Steroids 44-53-1510
Methandienone Anabolic Steroids 44-53-1510
Methandrostenolone Anabolic Steroids 44-53-1510
Methenolone Anabolic Steroids 44-53-1510
Methyltestosterone Anabolic Steroids 44-53-1510
Nandrolone Anabolic Steroids 44-53-1510
Norethandrolone Anabolic Steroids 44-53-1510
Oxandrolone Anabolic Steroids 44-53-1510
Oxymesterone Anabolic Steroids 44-53-1510
Oxymetholone Anabolic Steroids 44-53-1510
Stanozolol Anabolic Steroids 44-53-1510
Testosterone Anabolic Steroids 44-53-1510
2,5-dimethoxyamphetamine C-I 44-53-190(D)
3,4,5-trimethoxy amphetamine C-I 44-53-190(D)
3,4-methylenedioxy amphetamine C-I 44-53-190(D)
3,4-methylenedioxymethamphetamine (MDMA) C-I 44-53-190(D)
4-bromo-2,5-dimethoxyamphetamine C-I 44-53-190(D)
4-Methoxyamphetamine C-I 44-53-190(D)
4-methyl-2,5-dimethoxyamphetamine (STP) C-I 44-53-190(D)
5-methoxy-3,4-methylenedioxy amphetamine C-I 44-53-190(D)
Acetorphine C-I 44-53-190(C)
Acetyldihydrocodeine C-I 44-53-190(C)
Acetylmethadol C-I 44-53-190(B)
Alfentanyl C-I 44-53-190(B)
Allylprodine C-I 44-53-190(B)
Alphacetylmethadol C-I 44-53-190(B)
Alphameprodine C-I 44-53-190(B)
Alphamethadol C-I 44-53-190(B)
Alphamethylfentanyl (N-[1-(alpha-methyl-beta-phenyl) ethyl-4-piperidyl] propionanilide; 1-(1-methyl-2-phenylethyl-4-(N-pro-panilido) piperidine) C-I 44-53-190(B)
Any compound (not being bupropion) structurally derived from 2-amino-1-phenyl-1-propanone by modification in any of the following ways: (a) by substitution in the phenyl ring to any extent with alkyl, alkoxy, alkylenedioxy, haloalkyl or halide substituents, whether or not further substituted in the phenyl ring by one or more univalent substituents; (b) by substitution at the 3-position with an alkyl substituent; (c) by substitution at the nitrogen atom with alkyl or dialkyl groups, benzyl or methoxybenzyl groups; or (d) by inclusion of the nitrogen atom in a cyclic structure Including, but not limited to: Methylone, Mephedrone, 3,4-Methylenedioxypyrovalerone (MDPV), Butylone, Methedrone, 4-Methylethcathinone, Flephedrone, Pentylone, Pentedrone, Buphedrone C-I 44-53-190(F)
Benzethidine C-I 44-53-190(B)
Benzylmorphine C-I 44-53-190(C)
Betacetylmethadol C-I 44-53-190(B)
Betameprodine C-I 44-53-190(B)
Betamethadol C-I 44-53-190(B)
Betaprodine C-I 44-53-190(B)
Bufotenine C-I 44-53-190(D)
Cathinone C-I 44-53-190(F)
Clonitazene C-I 44-53-190(B)
Codeine methylbromide C-I 44-53-190(C)
Codeine-N-Oxide C-I 44-53-190(C)
Cyprenorphine C-I 44-53-190(C)
Desomorphine C-I 44-53-190(C)
Dextromoramide C-I 44-53-190(B)
Diampromide C-I 44-53-190(B)
Diethylthiambutene C-I 44-53-190(B)
Diethyltryptamine (DET) C-I 44-53-190(D)
Difenoxin C-I 44-53-190(B)
Dihydromorphine C-I 44-53-190(C)
Dimenoxadol C-I 44-53-190(B)
Dimepheptanol C-I 44-53-190(B)
Dimethylthiambutene C-I 44-53-190(B)
Dimethyltryptamine (DMT) C-I 44-53-190(D)
Dioxaphetyl butyrate C-I 44-53-190(B)
Dipipanone C-I 44-53-190(B)
Drotebanol C-I 44-53-190(C)
Ethylmethylthiambutene C-I 44-53-190(B)
Etonitazene C-I 44-53-190(B)
Etorphine C-I 44-53-190(C)
Etoxeridine C-I 44-53-190(B)
Fenethylline C-I 44-53-190(F)
Furethidine C-I 44-53-190(B)
Gamma Hydroxybutyric Acid C-I 44-53-190(E)
Heroin C-I 44-53-190(C)
Hydromorphinol C-I 44-53-190(C)
Hydroxypethidine C-I 44-53-190(B)
Ibogaine C-I 44-53-190(D)
Ketobemidone C-I 44-53-190(B)
Levomoramide C-I 44-53-190(B)
Levophenacylmorphan C-I 44-53-190(B)
Lysergic acid diethylamide (LSD) C-I 44-53-190(D)
Marijuana C-I 44-53-190(D)
Mecloqualone C-I 44-53-190(E)
Mescaline C-I 44-53-190(D)
Methaqualone C-I 44-53-190(E)
Methyldesorphine C-I 44-53-190(C)
Methylhydromorphine C-I 44-53-190(C)
Morpheridine C-I 44-53-190(B)
Morphine methylbromide C-I 44-53-190(C)
Morphine methylsulfonate C-I 44-53-190(C)
Morphine-N-Oxide C-I 44-53-190(C)
Myrophine C-I 44-53-190(C)
N-ethyl-3-piperidyl benzilate C-I 44-53-190(D)
N-ethylamphetamine C-I 44-53-190(F)
Nicocodeine C-I 44-53-190(C)
Nicomorphine C-I 44-53-190(C)
N-methyl-3-piperidyl benzilate C-I 44-53-190(D)
Noracymethadol C-I 44-53-190(B)
Norlevorphanol C-I 44-53-190(B)
Normethadone C-I 44-53-190(B)
Normorphine C-I 44-53-190(C)
Norpipanone C-I 44-53-190(B)
Parahexyl C-I 44-53-190(D)
Peyote C-I 44-53-190(D)
Phenadoxone C-I 44-53-190(B)
Phenampromide C-I 44-53-190(B)
Phenomorphan C-I 44-53-190(B)
Phenoperidine C-I 44-53-190(B)
Pholcodine C-I 44-53-190(C)
Piritramide C-I 44-53-190(B)
Proheptazine C-I 44-53-190(B)
Properidine C-I 44-53-190(B)
Propiram C-I 44-53-190(B)
Psilocybin C-I 44-53-190(D)
Psilocyn C-I 44-53-190(D)
Racemoramide C-I 44-53-190(B)
Substituted Cathinones C-I 44-53-190(F)
Synthetic Cannabinoid 24 (d.) Naphthylmethylindenes. Any compound containing a naphthylideneindene structure with substitution at the 3-position of the indene ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indene ring to any extent and whether or not substituted in the naphthyl ring to any extent C-I 44-53-190(D)
Synthetic Cannabinoid 24 (e.) Phenylacetylindoles. Any compound containing a 3-phenylacetylindole structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent. Including, but not limited to, SR-18, RCS-8, JWH-203, JWH-250, JWH-251, JWH-302 C-I 44-53-190(D)
Synthetic Cannabinoid 24 (f.) Cyclohexylphenols. Any compound containing a 2-(3-hydroxycyclohexyl)phenol structure with substitution at the 5-position of the phenolic ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not substituted in the cyclohexyl ring to any extent. Including, but not limited to, CP 47,497 (and homologues), cannabicyclohexanol, CP-55, 940. C-I 44-53-190(D)
Synthetic Cannabinoid 24 (h.) 2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo [1,2,3-de]-1, 4-benzoxazin-6-yl]-1-napthalenylmethanone (WIN 55,212-2) WIN 55,212-2 C-I 44-53-190(D)
Synthetic Cannabinoid 24 (i.) 9-(hydroxymethyl)-6,6-dimethy l-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol 7370 (HU-210, HU-211) HU-210, HU-211 C-I 44-53-190(D)
Synthetic Cannabinoid 24 (j.) Adamantoylindoles. Any compound containing a 3-(1-adamantoyl)indole structure with substitution at the nitrogen atom of the indole ring by a alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the adamantyl ring system to any extent Including but not limited to: AB-001, AB-002, AM1248 C-I 44-53-190(D)
Synthetic Cannabinoid 24(g.) Benzoylindoles. Any compound containing a 3-(benzoyl)indole structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent. Including, but not limited to, AM-694, Pravadoline (WIN 48,098), RCS-4, AM-630, AM-1241, AM-2233 C-I 44-53-190(D)
Synthetic Cannabinoid 24. (a.) Naphthoylindoles. Any compound containing a 3-(1-naphthoyl)indole structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the naphthyl ring to any extent. Including, but not limited to, JWH-015, JWH-018, JWH-019, JWH-073, JWH-081, JWH-122, JWH-200, JWH-210, JWH-398, AM-2201, WIN 55-212, AM-2201 (C1 analog), AM-1220 C-I 44-53-190(D)
Synthetic cannabinoid 24. (b.) Naphthylmethylindoles. Any compound containing a 1H-indol-3-yl-(1-naphthyl)methane structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the naphthyl ring to any extent Including but not limited to: JWH-175, JWH-184 C-I 44-53-190(D)
Synthetic Cannabinoid 24. (c.) Naphthoylpyrroles. Any compound containing a 3-(1-naphthoyl)pyrrole structure with substitution at the nitrogen atom of the pyrrole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the pyrrole ring to any extent and whether or not substituted in the naphthyl ring to any extent. Including, but not limited to, JWH-307, JWH-370, JWH-176 C-I 44-53-190(D)
Synthetic cannabinoids.--24. Any material, compound, mixture, or preparation that is not listed as a controlled substance in Schedule I through V, is not an FDA-approved drug, and contains any quantity of the following substances, their salts, isomers (whether optical, positional, or geometric), homologues, and salts of isomers and homologues, unless specifically excepted, whenever the existence of these salts, isomers, homologues, and salts of isomers and homologues is possible within the specific chemical designation. C-I 44-53-190(D)
Tetrahydrocannabinol (THC) C-I 44-53-190(D)
Thebacon C-I 44-53-190(C)
Thiophene analog of phencyclidine C-I 44-53-190(D)
Tilidine C-I 44-53-190(B)
Trimeperidine C-I 44-53-190(B)
Alphaprodine C-II 44-53-210(c)
Amobarbital C-II 44-53-210(f)
Amphetamine, its salts, optical isomers, and salts of its optical isomers C-II 44-53-210(d)
Anileridine C-II 44-53-210(c)
Any salt, compound, isomer, derivative, or preparation thereof which is chemically equivalent or identical with any of the substances referred to in paragraph (1), but not including the isoquinoline alkaloids of opium C-II 44-53-210(b)
Bezitramide C-II 44-53-210(c)
Coca leaves and any salt, compound, derivative, or preparation of coca leaves, and any salt, compound, derivative, or preparation thereof which is chemically equivalent or identical with any of these substances, but not including decocainized coca leaves or extractions which do not contain cocaine or ecgonine C-II 44-53-210(b)
Dextropropoxyphene [alpha-(+" )-4-dimethylamino-1, 2-diphenyl-3-methyl-2-propionoxybutane], in bulk form C-II 44-53-210(c)
Dihydrocodeine C-II 44-53-210(c)
Diphenoxylate C-II 44-53-210(c)
Fentanyl C-II 44-53-210(c)
Isomethadone C-II 44-53-210(c)
Levomethorphan C-II 44-53-210(c)
Levorphanol C-II 44-53-210(c)
Metazocine C-II 44-53-210(c)
Methadone C-II 44-53-210(c)
Methadone - Intermediate, 4-cyano-2-dimethylamino-4, 4-diphenyl butane C-II 44-53-210(c)
Methamphetamine, its salts, and salts of isomers C-II 44-53-210(d)
Methylphenidate C-II 44-53-210(d)
Moramide - Intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic acid C-II 44-53-210(c)
Opium and opiate, and any salt, compound, derivative, or preparation of opium or opiate, excluding Apomorphine, Nalbuphine, Naloxone, and Naltrexone, and their respective salts C-II 44-53-210(b)
Opium poppy and poppy straw C-II 44-53-210(b)
Pentazocine (to be administered by injection only) C-II 44-53-210(c)
Pentobarbital C-II 44-53-210(f)
Pethidine - Intermediate-A, 4-cyano-1-methyl-4-phenyl-piperidine C-II 44-53-210(c)
Pethidine - Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate C-II 44-53-210(c)
Pethidine - Intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid C-II 44-53-210(c)
Pethidine (meperidine) C-II 44-53-210(c)
Phenazocine C-II 44-53-210(c)
Phencyclidine immediate precursors: (a) 1-phenylcyclohexylamine; (b) 1-piperidinocyclohexanecarbonitrile (PCC); (g) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substance: (1) Immediate precursor to amphetamine and methamphetamine: (i) Phenylacetone, also known as phenyl-2-propanone; P2P; benzyl methyl ketone; methyl benzyl ketone. C-II 44-53-210(f)
Phencyclidine C-II 44-53-210(f)
Phenmetrazine and its salts C-II 44-53-210(d)
Phenylacetone (Immediate precurser to amphetamine or methamphetamine) phenyl-2-propanone, P2P, benzyl methyl ketone, methyl benzyl ketone C-II 44-53-210(g)
Piminodine C-II 44-53-210(c)
Racemethorphan C-II 44-53-210(c)
Racemorphan C-II 44-53-210(c)
Secobarbital C-II 44-53-210(f)
Sufentanil C-II 44-53-210(c)
any compound, mixture, or preparation containing amobarbital, secobarbital, pentobarbital or any salt thereof and one or more other active ingredients which are not listed in any schedule C-III 44-53-230(c)
any substance which contains any quantity of a derivative or barbituric acid or any salt thereof; C-III 44-53-230(c)
any suppository dosage form containing amobarbital, secobarbital, pentobarbital, or any salt of any of these drugs and approved by the United States Food and Drug Administration for marketing only as a suppository; C-III 44-53-230(c)
Benzphetamine C-III 44-53-230(b)
Chlorhexadol C-III 44-53-230(c)
Chlorphentermine C-III 44-53-230(b)
Clortermine C-III 44-53-230(b)
Gamma Hydroxybutyric Acid, and its salts, isomers, and salts of isomers contained in a drug product for which an application has been approved under Section 505 of the Federal Food, Drug and Cosmetic Act C-III 44-53-230(c)
Glutehimide C-III 44-53-230(c)
Lysergic Acid C-III 44-53-230(c)
Lysergic Acid Amide C-III 44-53-230(c)
Methyprylon C-III 44-53-230(c)
Nalorphene C-III 44-53-230(d)
Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium. C-III 44-53-230(e)
Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active, non-narcotic ingredients in recognized therapeutic amounts C-III 44-53-230(e)
Not more than 300 milligrams of ethylmorphine per 100 milliliters or not more than 15 milligrams per dosage unit, with one or more active, non-narcotic ingredients in recognized therapeutic amounts. C-III 44-53-230(e)
Not more than 50 milligrams of morphine per 100 milliliters or per 100 grams with one or more active, non-narcotic ingredients in recognized therapeutic amounts. C-III 44-53-230(e)
Not more than 500 milligrams of opium per 100 milliliters or per 100 grams, or not more than 25 milligrams per dosage unit, with one or more active, non-narcotic ingredients in recognized therapeutic amounts. C-III 44-53-230(e)
Phendimetrazine C-III 44-53-230(b)
Sulfondiethylmethane C-III 44-53-230(c)
Sulfonethylmethane C-III 44-53-230(c)
Sulfonmethane C-III 44-53-230(c)
Fenfluramine C-IV 44-53-250(c)
Alprazolam C-IV 44-53-250(a)
Barbital C-IV 44-53-250(a)
Bromazepam C-IV 44-53-250(a)
Butorphanol C-IV 44-53-250(g)
Camazepam C-IV 44-53-250(a)
Chloral Betaine C-IV 44-53-250(a)
Chloral Hydrate C-IV 44-53-250(a)
Chlordiazepoxide C-IV 44-53-250(a)
Clobazam C-IV 44-53-250(a)
Clonazepam C-IV 44-53-250(a)
Clorazepate C-IV 44-53-250(a)
Clotiazepam C-IV 44-53-250(a)
Cloxazolam C-IV 44-53-250(a)
Delorazepam C-IV 44-53-250(a)
Diazepam C-IV 44-53-250(a)
Diethylpropion C-IV 44-53-250(b)
Dosage forms of Dextropropoxyphene [Alpha-(+)-4-dimethylamino-1, 2-diphenyl-3-methyl-2-propionoxybutane] C-IV 44-53-250(e)
Estazolam C-IV 44-53-250(a)
Ethchlorvynol C-IV 44-53-250(a)
Ethinamate C-IV 44-53-250(a)
Ethyl Loflazepate C-IV 44-53-250(a)
Fludiazepam C-IV 44-53-250(a)
Flunitrazepam C-IV 44-53-250(a)
Flurazepam C-IV 44-53-250(a)
Halazepam C-IV 44-53-250(a)
Haloxazolam C-IV 44-53-250(a)
Ketazolam C-IV 44-53-250(a)
Loprazolam C-IV 44-53-250(a)
Lorazepam C-IV 44-53-250(a)
Lormetazepam C-IV 44-53-250(a)
Mazindol C-IV 44-53-250(b)
Mebutamate C-IV 44-53-250(a)
Medazepam C-IV 44-53-250(a)
Meprobamate C-IV 44-53-250(a)
Methohexital C-IV 44-53-250(a)
Methylphenobarbital C-IV 44-53-250(a)
Nimetazepam C-IV 44-53-250(a)
Nitrazepam C-IV 44-53-250(a)
Nordiazepam C-IV 44-53-250(a)
Not more than one milligram of difenoxin and not less than twenty-five micrograms of atropine sulfate per dosage unit. C-IV 44-53-250(e)
Oxazepam C-IV 44-53-250(a)
Oxazolam C-IV 44-53-250(a)
Paraldehyde C-IV 44-53-250(a)
Pemoline, including organometallic complexes and chelates thereof C-IV 44-53-250(b)
Pentazocine hydrochloride and acetaminophen, pentazocine hydrochloride and aspirin, and pentazocine and naloxone hydrochloride (all for oral administration only). C-IV 44-53-250(f)
Petrichloral C-IV 44-53-250(a)
Phenobarbital C-IV 44-53-250(a)
Phentermine C-IV 44-53-250(b)
Pinazepam C-IV 44-53-250(a)
Pipradol C-IV 44-53-250(b)
Prazepam C-IV 44-53-250(a)
SPA [(-)-1-Dimethylamino-1, 2-diphenylethane] C-IV 44-53-250(b)
Temazepam C-IV 44-53-250(a)
Tetrazepam C-IV 44-53-250(a)
Triazolam C-IV 44-53-250(a)
Not more than 200 milligrams of codeine per 100 milliliter or per 100 grams C-V 44-53-250(b)
Not more than 100 milligrams of dihydrocodeine per 100 milliliters or per 100 grams; C-V 44-53-250(b)
Not more than 100 milligrams of ethylmorphine per 100 milliliters or per 100 grams; C-V 44-53-250(b)
Not more than 100 milligrams of opium per 100 milliliters or per 100 grams C-V 44-53-250(b)
Not more than 2.5 milligrams of diphenoxylate and not less than 25 micrograms of atropine sulfate per dosage unit; C-V 44-53-250(b)
Not more than one-half milligram of difenoxin and not less than twenty-five micrograms of atropine sulfate per dosage unit. C-V 44-53-250(b)